We aimed to assess the effect of serum albumin level adjusted progesterone levels on the trigger day on clinical pregnancy rate in intracytoplasmic sperm injection cycles.
Introduction
Premature luteinization often presents with elevated serum progesterone levels during controlled ovarian hyperstimulation (1) . However, even in cases under LH suppression, significantly elevated serum progesterone levels may be observed in a subgroup of women (2) .
Several studies have demonstrated that this issue is indicative of both favorable and unfavorable outcomes in cases with premature increased progesterone (3) (4) (5) (6) . On the other hand, several studies have reported neither positive nor negative effects on outcome (7, 8) . A study with a high number of cycles introduced a cut-off value for progesterone of greater than 1.2 ng/mL as a significant predictor of poor outcome (3) . It has been proposed that supra-physiologic serum concentrations of estradiol secondary to ovarian hyperstimulation may lead to a premature increase in progesterone, which may interfere with endometrial receptivity and result in implantation failure (9, 10) . When released from steroidogenic cells, steroid hormones are mainly transported and presented in bound form. Most steroid hormones are bound to albumin; sex hormone-binding globulin, and corticosteroid-binding globulin while circulating in the blood. These proteins also have a function in regulating the non-protein-bound or 'free' forms (11) . Reduced albumin concentrations caused by some systemic disorders, including reductions in severe malnutrition, cirrhosis, and nephrotic syndrome were reported to alter the plasma distribution of some steroid hormones (12) .
The aim of this study was to assess the effect of serum albumin level adjusted progesterone levels on the trigger day on clinical pregnancy rates in intracytoplasmic sperm injection (ICSI) cycles.
Material and Method
This retrospective, single-center cohort study was performed with infertile women who underwent assisted reproductive technologies (ART) treatment in the IVF clinic of Zeynep Kamil Women and Children's Health Training and Research Hospital, Istanbul, between July 2016 and November 2016.
All participants underwent an ICSI cycles antagonist protocol in the ART center and had regular menstrual cycles (menstruation occurring every 28±4 days and lasting for about 5 days, with a physiological loss of approximately 30-70 mL of blood), normal serum prolactin levels and were without hormone treatment for 3 months. Patient ages ranged from 20 to 39 years old. All patients receiving assisted reproductive techniques were diagnosed with tubal factor infertility or poor ovarian reserve. Poor ovarian reserve was determined according to the following criteria: females over 35 years; a raised basal FSH level >10 IU/mL, irrespective of age; antral follicular count under 5 follicles; poor ovarian response or cycle cancellation in previous IVF cycle, irrespective of age. The definition of poor ovarian response in a previous cycle was oocyte yield under 5. Exclusion criteria were the cycle was cancellation due to failure of fertilization or poor embryo quality. After exclusion of 34 women with cycle cancellation, a total of 100 women undergoing ICSI cycles due to poor ovarian reserve or tubal factor infertility were included in this prospective study.
Follicle monitoring was performed by two dimensional sonographic measurements to observe growing follicles and calculate the mean value at each visit. An antagonist protocol was used in all cases. On the second day of the menstrual cycle, ampules of r-FSH (Gonal-F™, Merck-Sereno, Geneva, Switzerland) 225-300 IU were administered and follicular growth was monitored using transvaginal sonography (TVUSG). The dosage of r-FSH was adjusted from day 5 of stimulation according to the ovarian response. Antagonist (Cetrorelix™, Merck-Sereno, Geneva, Switzerland) 0.25 mg/day was administered when the follicular size was 12 mm. After the follicular size reached 18 mm, r-hCG (Ovitrelle™ 250 µg /0.5 mL Merck-Sereno, Geneva, Switzerland) was administered and follicular puncture was performed after 34-36 hours. Subsequently, 8% vaginal progesterone gel (Crinone™ Merck-Sereno, Geneva, Switzerland) was used two times per day. Elective single grade 1 embryo transfer was done on the 3rd or 5 th day in each case. Serum β-hCG level was measured after 2 weeks. Pregnancy was defined as a serum hCG level of 10 IU/L which observed 16 days after egg retrieval. The primary outcome was clinical pregnancy rate. Clinical pregnancy rate was defined as fetal heart beat(s) per transferred embryo.
Hormone assays
Blood samples were obtained on the day of β-hCG at 9-10 am for P4 level measurement and analyzed by radioimmunoassay with a sensitivity of 0.2 ng/mL (range of measurement was 0.2-40 ng/mL). The within-assay variability was 7-10% (13).
Serum albumin assays were carried out using standard laboratory methods (g/dL).
Statistical analysis
Data were analyzed using SPSS 15.0 (SPSS. Inc., Chicago, Ill., USA) for Windows. Student t test was used to compare continuous variables between the groups. Multivariate regression analyses were used to assess the adjusted associations. ROC analyses were used to assess the predictive value of the test and to calculate sensitivity and specificity. ANCOVA was used to compare adjusted means. P value <0.05 was accepted to be statistically significant.
Results
Among 100 cycles, there were 32 (32%) subjects with successful clinical pregnancy. Among cases with blastocyst transfer 5 (50 %) cases had successful clinical pregnancy whereas among 90 cases with cleavage stage embryo transfers, successful clinical pregnancy was observed in 27 (30 %) cases (p > 0.05). Serum albumin (4.5 g/dL vs. 4.5 g/dl) and progesterone levels (0.7 ng/mL vs. 0.5 ng/mL) were similar between groups with two different stage of embryo transfers (p > 0.05). There were 41 women who fulfilled the criteria for poor ovarian response while 59 women were normoresponders. Comparison of demographic and ovarian stimulation characteristics of groups with and without successful clinical pregnancy are summarized in table 1. In ROC analyses, progesterone level on the trigger day was found to be a significant predictor of successful clinical pregnancy (AUC=0.652, p=0.015). An optimal cut-off value of 0.55 ng/mL was obtained with 65% sensitivity and 57% specificity ( Figure 1 ). Albumin level adjusted progesterone concentrations on the trigger day were 0.67 ng/mL versus 0.64 ng/mL, but this difference was not statistically significant (p>0.05).
Figure 1: ROC curve analysis of the serum progesterone level
In multivariate regression analysis, progesterone and albumin levels on the trigger day and endometrial thickness were included in the model. After adjustment for progesterone and albumin levels, endometrial thickness was found to be significantly associated with successful clinical pregnancy (β = 0.39, sig= 0.038) ( Table 2 ).
Discussion
In this study, we wanted to determine the clinical importance of albumin adjusted progesterone concentrations on the trigger day for clinical pregnancy following ART. Our data showed a significant association between progesterone concentration on the trigger day and clinical pregnancy; however, this association barely remained significant after adjustment of progesterone concentrations for serum albumin levels. Although the majority of studies have focused on the effect of premature progesterone rise on endometrial receptivity, there are some studies indicating a detrimental effect of progesterone on the oocyte (14) . Additionally, several research studies have shown a critical role of albumin in maintaining the concentration gradient of steroids between the preovulatory follicular fluid and the circulation (15) . Based on the aforementioned data, we reasoned that high albumin level could bind to progesterone and prevent its detrimental effect on the endometrium. However, this was not the case for the effect of progesterone on oocyte quality. In our data we partially excluded the effect of progesterone increase on oocyte quality by including the cycles with high quality embryo transfer. Premature progesterone rise during ovarian hyperstimulation is not a novel issue, but still an interesting one (7) . Progesterone concentrations on the trigger day of more than 0.5 ng/mL were associated with a significantly lower rate of pregnancy (16) . While there is data indicating similar pregnancy rates between groups with p<1.5 ng/ml versus 1.5-2 ng/ml, authors suggest an optimal cut-off value of p ≤ 2ng/ml at the time of hCG (17) .
Another cut-off value was proposed to be ≥1.2 for the progesterone level on the day of hCG administration, with elevated pregnancy rates in polycystic ovary syndrome following a progesterone rise on the trigger day (18, 19) . In other studies, different cut-off values were determined for negative effects of premature progesterone rise on pregnancy outcome, such as p=0.9 ng/mL, 1.0 ng/mL, 1.7 ng/mL and 1.99 ng/mL (17, (20) (21) (22) . These variable results were proposed to be due to Another proposed model to estimate steroid hormone effects is the free androgen index, which is utilized to determine the main effect of testosterone after adjustment for serum binding protein (24) . A study conducted by Klebanoff MA showed that saliva is a valid substitute for plasma in assays of progesterone, even when concentrations of hormone and binding proteins are fluctuating. The authors concluded that salivary progesterone is a very good alternative to plasma for use in follow-up during pregnancy (25) .
From this point of view and based on the data indicating a high level of progesterone bound to albumin, we conducted this study, and our data revealed no detrimental effect of albumin adjusted premature progesterone rise on clinical pregnancy in ovarian hyperstimulation cycles in which high concentrations of steroid hormones are released into the circulation.
In conclusion, this study showed that progesterone levels oscillate in a narrow range and this is affected by serum albumin levels. Albumin adjusted progesterone concentrations may be more appropriate for determining candidates for a freeze-all policy. This conclusion was drawn from the data of small sample size so requires verification by further studies with wider study population. 
